Supplementary Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells Article Swipe
Fabien Almairac
,
Laurent Turchi
,
Nathalie Sakakini
,
David Nicolas Debruyne
,
Sarah Elkeurti
,
Elisabet Gjernes
,
Béatrice Polo
,
Laurence Bianchini
,
Denys Fontaine
,
Philippe Paquis
,
Hervé Chneiweiss
,
Marie‐Pierre Junier
,
Patrick Verrando
,
Fanny Burel‐Vandenbos
,
Thierry Virolle
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22425114
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1158/0008-5472.22425114
These figures describe that : dedifferentiation restores stem-like and tumorigenic properties (sup fig 5); EGFR and ERK inhibitions on the dedifferentiation process (sup fig 6 and 7).
Related Topics
Concepts
Homeobox protein NANOG
EGR1
MAPK/ERK pathway
Cell biology
Cancer research
Chemistry
Biology
Downregulation and upregulation
Embryonic stem cell
Kinase
Genetics
Gene
Induced pluripotent stem cell
Metadata
- Type
- preprint
- Language
- en
- Landing Page
- https://doi.org/10.1158/0008-5472.22425114
- OA Status
- gold
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4361877461
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4361877461Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1158/0008-5472.22425114Digital Object Identifier
- Title
-
Supplementary Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive CellsWork title
- Type
-
preprintOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-03-31Full publication date if available
- Authors
-
Fabien Almairac, Laurent Turchi, Nathalie Sakakini, David Nicolas Debruyne, Sarah Elkeurti, Elisabet Gjernes, Béatrice Polo, Laurence Bianchini, Denys Fontaine, Philippe Paquis, Hervé Chneiweiss, Marie‐Pierre Junier, Patrick Verrando, Fanny Burel‐Vandenbos, Thierry VirolleList of authors in order
- Landing page
-
https://doi.org/10.1158/0008-5472.22425114Publisher landing page
- Open access
-
YesWhether a free full text is available
- OA status
-
goldOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1158/0008-5472.22425114Direct OA link when available
- Concepts
-
Homeobox protein NANOG, EGR1, MAPK/ERK pathway, Cell biology, Cancer research, Chemistry, Biology, Downregulation and upregulation, Embryonic stem cell, Kinase, Genetics, Gene, Induced pluripotent stem cellTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4361877461 |
|---|---|
| doi | https://doi.org/10.1158/0008-5472.22425114 |
| ids.doi | https://doi.org/10.1158/0008-5472.22425114 |
| ids.openalex | https://openalex.org/W4361877461 |
| fwci | 0.0 |
| type | preprint |
| title | Supplementary Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells |
| biblio.issue | |
| biblio.volume | |
| biblio.last_page | |
| biblio.first_page | |
| topics[0].id | https://openalex.org/T12996 |
| topics[0].field.id | https://openalex.org/fields/13 |
| topics[0].field.display_name | Biochemistry, Genetics and Molecular Biology |
| topics[0].score | 0.987500011920929 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/1305 |
| topics[0].subfield.display_name | Biotechnology |
| topics[0].display_name | Cancer Research and Treatments |
| topics[1].id | https://openalex.org/T10336 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9840999841690063 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2730 |
| topics[1].subfield.display_name | Oncology |
| topics[1].display_name | Cancer Cells and Metastasis |
| topics[2].id | https://openalex.org/T10782 |
| topics[2].field.id | https://openalex.org/fields/22 |
| topics[2].field.display_name | Engineering |
| topics[2].score | 0.9800000190734863 |
| topics[2].domain.id | https://openalex.org/domains/3 |
| topics[2].domain.display_name | Physical Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2204 |
| topics[2].subfield.display_name | Biomedical Engineering |
| topics[2].display_name | Nanoplatforms for cancer theranostics |
| is_xpac | False |
| apc_list | |
| apc_paid | |
| concepts[0].id | https://openalex.org/C207701140 |
| concepts[0].level | 5 |
| concepts[0].score | 0.7587089538574219 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q420522 |
| concepts[0].display_name | Homeobox protein NANOG |
| concepts[1].id | https://openalex.org/C2780600689 |
| concepts[1].level | 4 |
| concepts[1].score | 0.6447606682777405 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q14864821 |
| concepts[1].display_name | EGR1 |
| concepts[2].id | https://openalex.org/C57074206 |
| concepts[2].level | 3 |
| concepts[2].score | 0.5674375891685486 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q14197552 |
| concepts[2].display_name | MAPK/ERK pathway |
| concepts[3].id | https://openalex.org/C95444343 |
| concepts[3].level | 1 |
| concepts[3].score | 0.505669355392456 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q7141 |
| concepts[3].display_name | Cell biology |
| concepts[4].id | https://openalex.org/C502942594 |
| concepts[4].level | 1 |
| concepts[4].score | 0.36711782217025757 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q3421914 |
| concepts[4].display_name | Cancer research |
| concepts[5].id | https://openalex.org/C185592680 |
| concepts[5].level | 0 |
| concepts[5].score | 0.33826303482055664 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q2329 |
| concepts[5].display_name | Chemistry |
| concepts[6].id | https://openalex.org/C86803240 |
| concepts[6].level | 0 |
| concepts[6].score | 0.28054380416870117 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[6].display_name | Biology |
| concepts[7].id | https://openalex.org/C127561419 |
| concepts[7].level | 3 |
| concepts[7].score | 0.2570182681083679 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q224527 |
| concepts[7].display_name | Downregulation and upregulation |
| concepts[8].id | https://openalex.org/C145103041 |
| concepts[8].level | 3 |
| concepts[8].score | 0.23659703135490417 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q1151519 |
| concepts[8].display_name | Embryonic stem cell |
| concepts[9].id | https://openalex.org/C184235292 |
| concepts[9].level | 2 |
| concepts[9].score | 0.22057288885116577 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q421851 |
| concepts[9].display_name | Kinase |
| concepts[10].id | https://openalex.org/C54355233 |
| concepts[10].level | 1 |
| concepts[10].score | 0.16444054245948792 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[10].display_name | Genetics |
| concepts[11].id | https://openalex.org/C104317684 |
| concepts[11].level | 2 |
| concepts[11].score | 0.08488389849662781 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[11].display_name | Gene |
| concepts[12].id | https://openalex.org/C107459253 |
| concepts[12].level | 4 |
| concepts[12].score | 0.06789341568946838 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q674925 |
| concepts[12].display_name | Induced pluripotent stem cell |
| keywords[0].id | https://openalex.org/keywords/homeobox-protein-nanog |
| keywords[0].score | 0.7587089538574219 |
| keywords[0].display_name | Homeobox protein NANOG |
| keywords[1].id | https://openalex.org/keywords/egr1 |
| keywords[1].score | 0.6447606682777405 |
| keywords[1].display_name | EGR1 |
| keywords[2].id | https://openalex.org/keywords/mapk/erk-pathway |
| keywords[2].score | 0.5674375891685486 |
| keywords[2].display_name | MAPK/ERK pathway |
| keywords[3].id | https://openalex.org/keywords/cell-biology |
| keywords[3].score | 0.505669355392456 |
| keywords[3].display_name | Cell biology |
| keywords[4].id | https://openalex.org/keywords/cancer-research |
| keywords[4].score | 0.36711782217025757 |
| keywords[4].display_name | Cancer research |
| keywords[5].id | https://openalex.org/keywords/chemistry |
| keywords[5].score | 0.33826303482055664 |
| keywords[5].display_name | Chemistry |
| keywords[6].id | https://openalex.org/keywords/biology |
| keywords[6].score | 0.28054380416870117 |
| keywords[6].display_name | Biology |
| keywords[7].id | https://openalex.org/keywords/downregulation-and-upregulation |
| keywords[7].score | 0.2570182681083679 |
| keywords[7].display_name | Downregulation and upregulation |
| keywords[8].id | https://openalex.org/keywords/embryonic-stem-cell |
| keywords[8].score | 0.23659703135490417 |
| keywords[8].display_name | Embryonic stem cell |
| keywords[9].id | https://openalex.org/keywords/kinase |
| keywords[9].score | 0.22057288885116577 |
| keywords[9].display_name | Kinase |
| keywords[10].id | https://openalex.org/keywords/genetics |
| keywords[10].score | 0.16444054245948792 |
| keywords[10].display_name | Genetics |
| keywords[11].id | https://openalex.org/keywords/gene |
| keywords[11].score | 0.08488389849662781 |
| keywords[11].display_name | Gene |
| keywords[12].id | https://openalex.org/keywords/induced-pluripotent-stem-cell |
| keywords[12].score | 0.06789341568946838 |
| keywords[12].display_name | Induced pluripotent stem cell |
| language | en |
| locations[0].id | doi:10.1158/0008-5472.22425114 |
| locations[0].is_oa | True |
| locations[0].source | |
| locations[0].license | cc-by |
| locations[0].pdf_url | |
| locations[0].version | acceptedVersion |
| locations[0].raw_type | posted-content |
| locations[0].license_id | https://openalex.org/licenses/cc-by |
| locations[0].is_accepted | True |
| locations[0].is_published | False |
| locations[0].raw_source_name | |
| locations[0].landing_page_url | https://doi.org/10.1158/0008-5472.22425114 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5079167931 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-0133-4091 |
| authorships[0].author.display_name | Fabien Almairac |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Fabien Almairac |
| authorships[0].is_corresponding | False |
| authorships[1].author.id | https://openalex.org/A5015933015 |
| authorships[1].author.orcid | https://orcid.org/0000-0003-2020-5831 |
| authorships[1].author.display_name | Laurent Turchi |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Laurent Turchi |
| authorships[1].is_corresponding | False |
| authorships[2].author.id | https://openalex.org/A5108071171 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Nathalie Sakakini |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Nathalie Sakakini |
| authorships[2].is_corresponding | False |
| authorships[3].author.id | https://openalex.org/A5004756545 |
| authorships[3].author.orcid | https://orcid.org/0000-0001-9033-890X |
| authorships[3].author.display_name | David Nicolas Debruyne |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | David Nicolas Debruyne |
| authorships[3].is_corresponding | False |
| authorships[4].author.id | https://openalex.org/A5003997958 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Sarah Elkeurti |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Sarah Elkeurti |
| authorships[4].is_corresponding | False |
| authorships[5].author.id | https://openalex.org/A5048678488 |
| authorships[5].author.orcid | https://orcid.org/0000-0001-9477-5904 |
| authorships[5].author.display_name | Elisabet Gjernes |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Elisabet Gjernes |
| authorships[5].is_corresponding | False |
| authorships[6].author.id | https://openalex.org/A5016788276 |
| authorships[6].author.orcid | |
| authorships[6].author.display_name | Béatrice Polo |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Beatrice Polo |
| authorships[6].is_corresponding | False |
| authorships[7].author.id | https://openalex.org/A5058696789 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-2840-8900 |
| authorships[7].author.display_name | Laurence Bianchini |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Laurence Bianchini |
| authorships[7].is_corresponding | False |
| authorships[8].author.id | https://openalex.org/A5004466761 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-5012-6769 |
| authorships[8].author.display_name | Denys Fontaine |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Denys Fontaine |
| authorships[8].is_corresponding | False |
| authorships[9].author.id | https://openalex.org/A5104858057 |
| authorships[9].author.orcid | https://orcid.org/0000-0002-0686-7866 |
| authorships[9].author.display_name | Philippe Paquis |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | Philippe Paquis |
| authorships[9].is_corresponding | False |
| authorships[10].author.id | https://openalex.org/A5060230145 |
| authorships[10].author.orcid | https://orcid.org/0000-0001-7675-5061 |
| authorships[10].author.display_name | Hervé Chneiweiss |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Herve Chneiweiss |
| authorships[10].is_corresponding | False |
| authorships[11].author.id | https://openalex.org/A5018387769 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-5731-0929 |
| authorships[11].author.display_name | Marie‐Pierre Junier |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Marie-Pierre Junier |
| authorships[11].is_corresponding | False |
| authorships[12].author.id | https://openalex.org/A5071527055 |
| authorships[12].author.orcid | |
| authorships[12].author.display_name | Patrick Verrando |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Patrick Verrando |
| authorships[12].is_corresponding | False |
| authorships[13].author.id | https://openalex.org/A5083225766 |
| authorships[13].author.orcid | https://orcid.org/0000-0001-8976-0126 |
| authorships[13].author.display_name | Fanny Burel‐Vandenbos |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Fanny Burel-Vandenbos |
| authorships[13].is_corresponding | False |
| authorships[14].author.id | https://openalex.org/A5020606582 |
| authorships[14].author.orcid | https://orcid.org/0000-0003-1464-0917 |
| authorships[14].author.display_name | Thierry Virolle |
| authorships[14].author_position | last |
| authorships[14].raw_author_name | Thierry Virolle |
| authorships[14].is_corresponding | False |
| has_content.pdf | False |
| has_content.grobid_xml | False |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1158/0008-5472.22425114 |
| open_access.oa_status | gold |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Supplementary Data from ERK-Mediated Loss of miR-199a-3p and Induction of EGR1 Act as a “Toggle Switch” of GBM Cell Dedifferentiation into NANOG- and OCT4-Positive Cells |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12996 |
| primary_topic.field.id | https://openalex.org/fields/13 |
| primary_topic.field.display_name | Biochemistry, Genetics and Molecular Biology |
| primary_topic.score | 0.987500011920929 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/1305 |
| primary_topic.subfield.display_name | Biotechnology |
| primary_topic.display_name | Cancer Research and Treatments |
| related_works | https://openalex.org/W2092215419, https://openalex.org/W1987438955, https://openalex.org/W2148445634, https://openalex.org/W2009037891, https://openalex.org/W1521411817, https://openalex.org/W1982459028, https://openalex.org/W2381340599, https://openalex.org/W2071141381, https://openalex.org/W4361877569, https://openalex.org/W4362423341 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1158/0008-5472.22425114 |
| best_oa_location.is_oa | True |
| best_oa_location.source | |
| best_oa_location.license | cc-by |
| best_oa_location.pdf_url | |
| best_oa_location.version | acceptedVersion |
| best_oa_location.raw_type | posted-content |
| best_oa_location.license_id | https://openalex.org/licenses/cc-by |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | False |
| best_oa_location.raw_source_name | |
| best_oa_location.landing_page_url | https://doi.org/10.1158/0008-5472.22425114 |
| primary_location.id | doi:10.1158/0008-5472.22425114 |
| primary_location.is_oa | True |
| primary_location.source | |
| primary_location.license | cc-by |
| primary_location.pdf_url | |
| primary_location.version | acceptedVersion |
| primary_location.raw_type | posted-content |
| primary_location.license_id | https://openalex.org/licenses/cc-by |
| primary_location.is_accepted | True |
| primary_location.is_published | False |
| primary_location.raw_source_name | |
| primary_location.landing_page_url | https://doi.org/10.1158/0008-5472.22425114 |
| publication_date | 2023-03-31 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index.6 | 24 |
| abstract_inverted_index.: | 4 |
| abstract_inverted_index.on | 18 |
| abstract_inverted_index.5); | 13 |
| abstract_inverted_index.ERK | 16 |
| abstract_inverted_index.and | 8, 15, 25 |
| abstract_inverted_index.fig | 12, 23 |
| abstract_inverted_index.the | 19 |
| abstract_inverted_index.(sup | 11, 22 |
| abstract_inverted_index.EGFR | 14 |
| abstract_inverted_index.that | 3 |
| abstract_inverted_index.figures | 1 |
| abstract_inverted_index.process | 21 |
| abstract_inverted_index.describe | 2 |
| abstract_inverted_index.restores | 6 |
| abstract_inverted_index.stem-like | 7 |
| abstract_inverted_index.properties | 10 |
| abstract_inverted_index.inhibitions | 17 |
| abstract_inverted_index.tumorigenic | 9 |
| abstract_inverted_index.7).</p> | 26 |
| abstract_inverted_index.<p>These | 0 |
| abstract_inverted_index.dedifferentiation | 5, 20 |
| cited_by_percentile_year | |
| countries_distinct_count | 0 |
| institutions_distinct_count | 15 |
| citation_normalized_percentile.value | 0.09719048 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |